Unibest
← Back to patent-cliff list

CAS 1420478-87-0

benzyl (S)-2-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate

Codes: ACAT-006

Application context (from source-drug indications)

Mantle cell lymphomaAcalabrutinibChronic lymphocytic leukaemiaAcalabrutinibLymphocytic leukaemiaAcalabrutinib

Source drugs (routes using this intermediate)

DrugTierExpiry
AcalabrutinibTier A — Act now2030

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Qualified Partner — East China API Works2-Butynoic Acid
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site2-Butynoyl Chloride
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site3-Chloro-2-pyrazinemethanamine hydrochloride
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Works(S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5 -a]pyrazin-3- yl)pyrrolidine-1-carboxylate
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site[4-[(Pyridin-2-yl)carbamoyl]phenyl]boronic acid
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site4-[8-Amino-3-(2S)-2-pyrrolidinylimidazo[1,5 -a]pyrazin-1-yl]-N-2- pyridinylbenzamide
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.